In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Cesarean delivery (CD) is recommended in preterm breech births at 32 weeks’ gestation or sooner, according to a recent study published in the American Journal of Obstetrics & Gynecology.1
Short- and long-term outcomes of very preterm (VPT) and extremely preterm (EPT) births are likely influenced by the mode of delivery.2 CD is currently not recommended for preterm birth by guidelines, but a CD rate of 55% has been reported for VPT births.1
CD may lead to complications such as respiratory disease syndrome (RDS), maternal morbidities, and subsequent preterm birth. However, this method of delivery may also reduce neonatal morbidity and intraventricular hemorrhage (IVH) risk in the case of preterm birth. This makes it difficult to determine the optimal mode of delivery.
To evaluate the link between mode of delivery and neonatal morbidity and mortality among births occurring at 32 weeks’ gestation or sooner, investigators conducted a systematic review and meta-analysis. Literature was identified through searches of the MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases.
Two independent authors performed title, abstract, and full text screening, with a third author consulted to resolve disagreements. Studies evaluating preterm pregnancies up to 32 weeks’ gestation were eligible for inclusion.
Pregnancies with imminent threats to the mother or fetus were excluded from the analysis. Neonatal mortality and severe IVH were reported as the primary outcomes, separated by mode of delivery.
Secondary outcomes included Apgar scores at 1 and 5 minutes, RDS, periventricular leukomalacia (PVL), bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), necrotizing enterocolitis (NEC), late neurodevelopmental complications, early onset sepsis, late-onset sepsis, and maternal morbidities.
Data extractions was performed by 2 independent authors using Microsoft Excel 2019. Relevant data included first author, year of publications, country, study design, study duration, study population, number of participants, object identifier, outcome events, and mode of delivery.
There were 17 studies included in the quantitative analysis and 19 in the qualitative analysis. All studies were cohort studies, and 9 reported on the actual mode of delivery, 6 the planned mode of delivery, and 2 both the planned and actual mode of delivery.
Across 9 studies evaluating the link between mode of delivery and mortality among preterm infants, a pooled odds ratio (OR) of 0.62 was reported for actual CD, indicating significantly improved survival. For planned CD vs planned vaginal delivery (VD), no significant difference was noted, with an OR of 0.87.
Mortality odds were not significantly impacted by CD in singleton vertex preterm pregnancies, with an OR of 0.90. However, among singleton breach pregnancies, an OR of 0.34 for death was reported among infant born through actual CD vs actual VD, indicating a 66% reduced risk of mortality. For planned CD and VD, this OR was 0.56.
When evaluating the odds of IVH based on mode of delivery, significantly reduced odds were reported among CD infants during VD infants, with an OR of 0.70. However, severe IVH risks did not differ based on planned or actual mode of delivery. PVL and ROP odds also did not differ between delivery methods.
For BPD, no significant difference in risk was reported based on the planned mode of delivery. However, when evaluating the actual mode of delivery, reduced odds were identified from CD in 1 study. NEC rates also did not differ between methods, but 1 study reported higher sepsis odds in CD infants. Apgar scores did not differ between groups.
These results indicated reduced mortality without increased morbidity from CD in VPT and EPT breech infants. Investigators concluded routine CD is preferred for preterm singleton breech pregnancies at 32 weeks’ gestation or sooner.
References
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More